Editorial

Antiretroviral therapy optimisation in the time of COVID-19: Is it really different in North and South Africa?

Ahmed Cordie, Menna-t-allah El-Kotamy, Gamal Esmat
Southern African Journal of HIV Medicine | Vol 21, No 1 | a1118 | DOI: https://doi.org/10.4102/sajhivmed.v21i1.1118 | © 2020 Ahmed Cordie, Menna-t-allah El-Kotamy, Gamal Esmat | This work is licensed under CC Attribution 4.0
Submitted: 23 June 2020 | Published: 30 July 2020

About the author(s)

Ahmed Cordie, Endemic Medicine Department, Cairo University Hospitals, Cairo, Egypt
Menna-t-allah El-Kotamy, Egyptian Patent Office, Academy of Scientific Research and Technology, Cairo, Egypt
Gamal Esmat, Endemic Medicine Department, Cairo University Hospitals, Cairo, Egypt


Share this article

Bookmark and Share

Abstract

No abstract available.

Keywords

HIV; ART; differentiated service delivery; stable; COVID-19; pandemic; stock-outs; WHO; low to middle income countries; locally-manufactured; TDF/FTC combination; patent

Metrics

Total abstract views: 238
Total article views: 72


Crossref Citations

No related citations found.